Tesamorelin – 10mg
£70.00
Description
Tesamorelin is a synthetic research peptide and a structural analogue of GHRH (growth hormone-releasing hormone). It has been clinically studied for visceral fat signalling and metabolic biomarkers, with ongoing investigation in areas related to fat metabolism and lean-tissue pathways.
Tesamorelin works by stimulating the pituitary gland to increase the body’s own growth hormone (GH) release in a natural, pulsatile rhythm. In research, this GH signalling has been shown to elevate downstream IGF-1, a key mediator involved in lipolysis (fat-breakdown signalling) and lean-tissue metabolic activity. Studies highlight particular activity in visceral adipose research models, with continued investigation into broader metabolic and tissue-repair biomarkers.
This compound is referenced strictly in the context of laboratory and pre-clinical research and is supplied for research purposes only, not for human consumption.
Tesamorelin is a synthetic research peptide and a structural analogue of GHRH (growth hormone-releasing hormone). It has been clinically studied for visceral fat signalling and metabolic biomarkers, with ongoing investigation in areas related to fat metabolism and lean-tissue pathways.
Tesamorelin works by stimulating the pituitary gland to increase the body’s own growth hormone (GH) release in a natural, pulsatile rhythm. In research, this GH signalling has been shown to elevate downstream IGF-1, a key mediator involved in lipolysis (fat-breakdown signalling) and lean-tissue metabolic activity. Studies highlight particular activity in visceral adipose research models, with continued investigation into broader metabolic and tissue-repair biomarkers.
This compound is referenced strictly in the context of laboratory and pre-clinical research and is supplied for research purposes only, not for human consumption.
Reviews
There are no reviews yet.